Despite the rancor, there are many bipartisan opportunities for the divided 118 th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback